Craft

Boehringer Ingelheim

Revenue

€8.9 B

FY, 2021

Boehringer Ingelheim Summary

Company Summary

Overview
Boehringer Ingelheim International is a pharmaceutical company specializing in animal health, human pharma, and biopharmaceutical contract manufacturing. It offers treatments for heart, metabolic, and chronic kidney diseases, cancer, mental disorders, skin and inflammatory diseases, etc. The company also provides products for dogs, cats, horses, pigs, cattle, and poultry.
Type
Subsidiary
Status
Active
Founded
1958
HQ
Ingelheim am Rhein, DE | view all locations
Website
https://www.boehringer-ingelheim.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Hubertus von Baumbach

    Hubertus von Baumbach, Chairman of the Board of Managing Directors

    • Michael Betke-Hornfeck

      Michael Betke-Hornfeck, Chief Purchasing Officer

    • Sven Sommerlatte

      Sven Sommerlatte, Chief Human Resources Officer

    • Carinne Brouillon

      Carinne Brouillon, Member of the Board of Managing Directors, Human Pharma Business Unit

    Operating MetricsView all

    Trademark Applications

    1.1K

    Feb, 2024

    Trademarks

    5.2K

    Feb, 2024

    Products

    73

    Feb, 2024

    LocationsView all

    81 locations detected

    • Ingelheim am Rhein, RP HQ

      Germany

      Binger Str. 173

    • Duluth, GA

      United States

      3239 Satellite Blvd NW

    • Fremont, CA

      United States

      6701 Kaiser Dr

    • Ridgefield, CT

      United States

      900 Ridgebury Rd

    • Ouled Fayet, Wilaya d'Alger

      Algeria

      29 Coopérative El-Yasmine

    • Munro, BA

      Argentina

      Complejo Empresarial Urbana Cazadores de Coquimbo 2841 Piso 2

    and 75 others

    Boehringer Ingelheim Financials

    Summary Financials

    Revenue (FY, 2021)
    €8.9B
    Gross profit (FY, 2021)
    €6.0B
    Net income (FY, 2021)
    €2.2B
    Cash (FY, 2021)
    €350.0K
    EBIT (FY, 2021)
    €1.3B

    Footer menu